St. Jude findings highlight genomic analysis as a tool to extend risk-directed therapy and improve outcomes for children with the most common pediatric cancer.
Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
Results from a collaborative multi-site clinical trial show the success of adding brentuximab vedotin, reducing radiation.
Martine Roussel, Ph.D., has been elected to the 2021 Class of Fellows of the American Association for Cancer Research.
Scientists at St. Jude are studying how signals sent from skeletal muscle affect the brain.
Scientists at St. Jude Children’s Research Hospital are learning more about what the molecular groups of a rare pediatric brain tumor mean for clinical care.
St. Jude scientists have been selected for an international collaborative research effort to advance treatment for some leading causes of childhood cancer death.
An international research team has identified clinical factors associated with the risk of central nervous system relapse in patients with the most common childhood cancer.
Five-year grant will aid in the study of mechanisms underlying neurodegenerative diseases like ALS.
St. Jude is dedicating staff and resources to focus on the prevention of human papillomavirus (HPV)-related cancers around the world through HPV vaccine awareness programming.
St. Jude scientists are studying the risk factors associated with cancer treatments and its effects on cognition.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.